2-{2-[4-(4-Fluoro-phenyl)piperazin-1-yl]-2-oxoethyl}-6-(morpholin-4-yl) -4-phenyl-pyridazin-3(2H)-one

Aydin A., Şüküroǧlu M., Akkurt M., Büyükgüngör O.Aydin, A, Sukuroglu, M, Akkurt, M, Buyukgungor, O2023-05-092023-05-092011-03-012011.01.011600-5368https://hdl.handle.net/20.500.12597/13318In the title compound, C26H28FN5O 3, the morpholine ring adopts a chair conformation. The piperazine ring is puckered [QT = 0.5437 (15) Å, θ = 8.89 (15) and φ = 357.2 (11)°]. The 1,6-dihydropyridazine ring makes dihedral angles of 28.03 (7) and 77.46 (7)° with the phenyl and benzene rings, respectively. In the crystal, molecules are linked along the c axis by C - H⋯O interactions and are flattened parallel to the ac plane. C - H⋯π interactions also contribute to the stability of the structure.true2-{2-[4-(4-Fluoro-phenyl)piperazin-1-yl]-2-oxoethyl}-6-(morpholin-4-yl) -4-phenyl-pyridazin-3(2H)-one2-{2-[4-(4-Fluorophenyl)piperazin-1-yl]-2-oxoethyl}-6-(morpholin-4-yl)-4-phenylpyridazin-3(2H)-oneArticle10.1107/S160053681100507110.1107/S16005368110050712-s2.0-79952403538WOS:000287820000189O666U215967